Return to home page
Searching: Muskingum library catalog
In response to the COVID-19 outbreak, statewide lending via OhioLINK and SearchOhio has been suspended. OPAL member libraries have closed or are operating at reduced service levels. Please contact your library with specific lending requests or if you need assistance.
  Previous Record Previous Item Next Item Next Record
  Reviews, Summaries, etc...
Title New therapeutic agents in thrombosis and thrombolysis / edited by Arthur A. Sasahara, Joseph Loscalzo.
Imprint New York : M. Dekker, [1997]

View online
View online
Subject Thrombolytic therapy.
Fibrinolytic agents.
Thrombolytic Therapy.
Thrombosis -- drug therapy.
Fibrinolytic Agents.
Hemostasis -- drug effects.
Alt Name Sasahara, Arthur A. (Arthur Asao), 1927-
Loscalzo, Joseph.
NetLibrary, Inc.
Description xiv, 681 pages : illustrations ; 26 cm
polychrome rdacc
Bibliography Note Includes bibliographical references and index.
Reproduction Electronic reproduction. Boulder, Colo. : NetLibrary, 2001. Available via World Wide Web. Access may be limited to NetLibrary affiliated libraries.
ISBN 0585347735 (electronic bk.) : $195.00
082479866X (hardcover : alk. paper)
OCLC # 47011204
Additional Format Original (DLC) 97012542 (OCoLC)36682384.
Table of Contents
1Overview of Hemostasis and Fibrinolysis / Joseph Loscalzo, Andrew I. Schafer1
2A Survey of Animal Modes to Develop New and Novel Antithrombotic Agents / Walter Jeske, Demetra D. Callas, Brigitte Kaiser [et al.]9
3Experimental Strategies for Assessing Antithrombotic Benefits and Hemorrhagic Risks of Novel Antithrombotic Agents / Laurence A. Harker, Stephen R. Hanson29
4Design Issues in Clinical Trials of Thrombolytic and Antithrombotic Agents / Dina S. Stolman, Jay P. Siegel, Marc K. Walton [et al.]49
5Overview of New Developments in Heparins, Thrombin Inhibitors, and Other New and Novel Agents / Jeffrey I. Weitz, Jack Hirsh77
6Low-Molecular-Weight Heparins: Biochemistry and Pharmacology / Meyer Michel Samama, Pierre Claude Desnoyers87
7Low-Molecular-Weight Heparins: Prophylaxis of Venous Thrombosis / Vijay Vir Kakkar103
8Low-Molecular-Weight Heparins: Treatment of Venous Thromboembolism / Philomeen M. M. Kuijer, Martin H. Prins, Harry Roger Buller129
9Direct Thrombin Inhibitors: Active-Site Inhibitors of Thrombin / Jules A. Shafer143
10Direct Thrombin Inhibitors in Venous Thromboembolism / Mark A. Crowther, Jeffrey S. Ginsberg159
11Direct Thrombin Inhibitors in Arterial Thrombosis / Bernard Rudolph Erickson, Eric Jeffrey Topol169
12Direct Thrombin Inhibitors: Hirulog / John M. Maraganore191
13Modulation of the Protein C Pathway as a Therapy for Thrombosis / Charles T. Esmon209
14Tissue Factor Pathway Inhibitor / Thomas J. Girard225
15Direct Factor Xa Inhibitors / George P. Vlasuk261
16Overview of Inhibition of Platelet Functions / James T. Willerson, Claude R. Benedict285
17Pharmacology and Clinical Development of Abciximab (c7E3 Fab, ReoPro): A Monoclonal Antibody Inhibitor of GPIIb/IIIa and [actual symbol not reproducible] / Robert E. Jordan, Mary Ann Mascelli, Marian T. Nakada [et al.]291
18Clinical Use of a Monoclonal Antibody to the Platelet Glycoprotein IIb/IIIa Receptor / James J. Ferguson, James T. Willerson315
19Integrilin: Synthetic Peptides Against the Platelet Glycoprotein IIb/IIIa Receptor / Barbara E. Tardiff, Julie M. Miller, Robert A. Harrington [et al.]333
20Tirofiban, a Nonpeptide Inhibitor of the Platelet Glycoprotein IIb/IIIA Receptor / Lawrence I. Deckelbaum, Frederic L. Sax, William Grossman355
21Aurin Tricarboxylic Acid: Inhibitor of von Willebrand Factor Attachment to Platelet GPIb / Martin D. Phillips, Joel L. Moake367
22Antagonism of Platelet Glycoprotein Ib Receptors: Protective Effects in Injured Coronary Arteries / James T. Willerson385
23Oxygen-Derived Free Radicals and Arterial Thrombosis / Paolo Golino407
24Platelet Procoagulant Activity / Permual Thiagarajan, Claude R. Benedict419
25Development of Unstable Angina and Myocardial Infarction: Importance of Platelets, Platelet- and Endothelium-Derived Mediators, and Monocytes/Macrophages in Thrombosis, Vasoconstriction, and Neointimal Proliferation / James T. Willerson435
26Introduction to the Section on New Thrombolytic Agents / Marc Verstraete449
27Animal Models to Assess the Safety and Efficacy of Thrombolytic Agents / Jean Marie Stassen451
28Biochemistry, Pharmacology, and Initial Clinical Experience with TNK-tPa / E. R. McCluskey, Bruce A. Keyt, Canio J. Refino [et al.]475
29Clinical and Preclinical Profile of the Novel Recombinant Plasminogen Activator Reteplase / Ulrich Martin495
30Recombinant Urokinase (r-UK): Biochemistry, Pharmacology, and Clinical Experience / R. Bruce Credo, Sandra E. Burke, Walter M. Barker [et al.]513
31Pro-urokinase: History, Mechanisms of Action, and Clinical Development / Victor Gurewich539
32Recombinant Glycosylated Pro-urkinase: Biochemistry, Pharmacology, and Early Clinical Experience / R. Bruce Credo, Sandra E. Burke, Walter M. Barker [et al.]561
33Recombinant Staphylokinase for Thrombolytic Therapy / Steven Vanderschueren, Frans Van de Werf, Desire Collen591
34Desmodus rotundus (Vampire Bat) Plasminogen Activator [actual symbol not reproducible]: A Superior Thrombolytic Created by Evolution / Wolf-Dieter Schleuning, Akhileshwar Bhargava, Peter Donner603
35Antibody Targeting: A Strategy for Improving Thrombolytic Therapy / Edgar Haber625
36Thrombolytic Agents in Development / Marc Verstraete, Fedor Bachmann639

If you experience difficulty accessing or navigating this content, please contact the OPAL Support Team